{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T09:10:11Z","timestamp":1683882611299},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.mehy.2007.04.016","type":"journal-article","created":{"date-parts":[[2007,6,8]],"date-time":"2007-06-08T16:54:36Z","timestamp":1181321676000},"page":"137-140","source":"Crossref","is-referenced-by-count":1,"title":["Does autoimmunity of endogenous vasoactive neuropeptides cause retinopathy in humans?"],"prefix":"10.1016","volume":"70","author":[{"given":"Donald R.","family":"Staines","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mehy.2007.04.016_bib1","first-page":"53","article-title":"Ocular neuropeptides","volume":"60","author":"Tervo","year":"1982","journal-title":"Med Biol"},{"issue":"4","key":"10.1016\/j.mehy.2007.04.016_bib2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1006\/exer.1994.1039","article-title":"Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase","volume":"58","author":"Nillson","year":"1994","journal-title":"Exp Eye Res"},{"issue":"9","key":"10.1016\/j.mehy.2007.04.016_bib3","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1182\/blood-2005-11-4497","article-title":"Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells","volume":"107","author":"Gonzalez-Rey","year":"2006","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2007.04.016_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/NMM:7:1-2:003","article-title":"Class II G protein-coupled receptors and their ligands in neuronal function and protection","volume":"7","author":"Martin","year":"2005","journal-title":"Neuromol Med"},{"issue":"1","key":"10.1016\/j.mehy.2007.04.016_bib5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0006-8993(94)91825-2","article-title":"PACAP is a potent and highly effective stimulator of adenylyl cyclase activity in the retinas of different mammalian species","volume":"641","author":"Onali","year":"1994","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.mehy.2007.04.016_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/17402520600568252","article-title":"Postulated vasoactive neuropeptide autoimmunity in fatigue-related conditions: a brief review and hypothesis","volume":"13","author":"Staines","year":"2006","journal-title":"Clin Dev Immunol"},{"issue":"5\u20136","key":"10.1016\/j.mehy.2007.04.016_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/10445490260099746","article-title":"Ocular immune privilege and the impact of intraocular inflammation","volume":"21","author":"Streilein","year":"2002","journal-title":"DNA Cell Biol"},{"issue":"1","key":"10.1016\/j.mehy.2007.04.016_bib8","first-page":"16","article-title":"Role of immunological factors in peripheral vitreo-chorioretinal dystrophies and macular ruptures of the retina","volume":"111","author":"Balashova","year":"1995","journal-title":"Vestn Oftalmol"},{"issue":"2","key":"10.1016\/j.mehy.2007.04.016_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1568-9972(02)00127-1","article-title":"Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy","volume":"2","author":"Adamus","year":"2003","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.mehy.2007.04.016_bib10","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archopht.118.11.1525","article-title":"Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration","volume":"118","author":"Heckenlively","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.mehy.2007.04.016_bib11","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.4049\/jimmunol.151.6.3381","article-title":"Retina and retinal pigment epithelial cell autoantibodies are produced during murine coronavirus retinopathy","volume":"151","author":"Hooks","year":"1993","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.mehy.2007.04.016_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0165-5728(01)00374-5","article-title":"Blood\u2013retinal barrier breakdown in experimental coronavirus retinopathy: association with viral antigen, inflammation, and VEGF in sensitive and resistant strains","volume":"119","author":"Vinores","year":"2002","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.mehy.2007.04.016_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1167\/iovs.06-0510","article-title":"Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes","volume":"48","author":"Zheng","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.mehy.2007.04.016_bib14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2990.2003.00499.x","article-title":"The pathology and pathogenesis of retinal vasculitis","volume":"29","author":"Hughes","year":"2003","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"10.1016\/j.mehy.2007.04.016_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1620\/tjem.196.167","article-title":"Effect of phosphodiesterase inhibitors on nitric oxide production by glial cells","volume":"196","author":"Yoshikawa","year":"2002","journal-title":"Tohoku J Exp Med"},{"issue":"7","key":"10.1016\/j.mehy.2007.04.016_bib16","first-page":"2006","article-title":"Stimulation of cyclic adenosine monophosphate accumulation causes breakdown of the blood\u2013retinal barrier","volume":"32","author":"Sen","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.mehy.2007.04.016_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.preteyeres.2007.01.004","article-title":"Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy","volume":"26","author":"Toda","year":"2007","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.mehy.2007.04.016_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000099274","article-title":"Intermediate and posterior uveitis","volume":"92","author":"Forrester","year":"2007","journal-title":"Chem Immunol Allergy"},{"issue":"2","key":"10.1016\/j.mehy.2007.04.016_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1096-9861(20000306)418:2<147::AID-CNE2>3.0.CO;2-#","article-title":"PACAP and glutamate are co-stored in the retinohypothalamic tract","volume":"418","author":"Hannibal","year":"2000","journal-title":"J Comp Neurol"},{"issue":"1","key":"10.1016\/j.mehy.2007.04.016_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0006-8993(99)01690-X","article-title":"Attenuation by PACAP of glutamate-induced neurotoxicity in cultured retinal neurons","volume":"839","author":"Shoge","year":"1999","journal-title":"Brain Res"},{"issue":"Part 8","key":"10.1016\/j.mehy.2007.04.016_bib21","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"issue":"2\u20133","key":"10.1016\/j.mehy.2007.04.016_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/08830180212068","article-title":"Experimental autoimmune uveitides: multiple antigens, diverse diseases","volume":"21","author":"Adamus","year":"2002","journal-title":"Int Rev Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2007.04.016_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/bjo.2006.099192","article-title":"Supplementation of CD4+CD25+ regulatory cells suppresses experimental autoimmune uveoretinitis","volume":"91","author":"Keino","year":"2007","journal-title":"Brit J Ophthalmol"},{"key":"10.1016\/j.mehy.2007.04.016_bib24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1196\/annals.1317.011","article-title":"Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo: therapeutic applications in autoimmunity and transplantation","volume":"1070","author":"Chorny","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.mehy.2007.04.016_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/09273940490912399","article-title":"The immunomodulator vasoactive intestinal peptide (VIP) does not affect experimental autoimmune uveitis (EAU) in B10.R111 mice","volume":"13","author":"Chen","year":"2005","journal-title":"Ocul Immunol Onflamm"},{"issue":"3","key":"10.1016\/j.mehy.2007.04.016_bib26","first-page":"137","article-title":"Translational research with experimental autoimmune uveoretinitis (EAU)","volume":"111","author":"Usui","year":"2007","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"8","key":"10.1016\/j.mehy.2007.04.016_bib27","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archopht.122.8.1179","article-title":"Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide","volume":"122","author":"Keino","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"65","key":"10.1016\/j.mehy.2007.04.016_bib28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.mehy.2005.02.014","article-title":"Do cytosine guanine dinucleotide (CpG) fragments induce vasoactive neuropeptide mediated fatigue-related autoimmune disorders?","author":"Staines","year":"2005","journal-title":"Med Hypotheses"},{"issue":"65","key":"10.1016\/j.mehy.2007.04.016_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mehy.2005.02.013","article-title":"Are vasoactive neuropeptide autoimmune fatigue-related disorders mediated via G protein-coupled receptors?","author":"Staines","year":"2005","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1016\/j.mehy.2007.04.016_bib30","first-page":"45","article-title":"Pathology of the organ of vision in chronic fatigue syndrome","volume":"119","author":"Frolov","year":"2003","journal-title":"Vestn Oftalmol"},{"issue":"12","key":"10.1016\/j.mehy.2007.04.016_bib31","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/intimm\/dxl103","article-title":"Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis","volume":"18","author":"Sun","year":"2006","journal-title":"Int Immunol"},{"issue":"6","key":"10.1016\/j.mehy.2007.04.016_bib32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2174\/1389450054863644","article-title":"Protein kinase A (PKA) \u2013 a potential target for therapeutic intervention of dysfunctional immune cells","volume":"6","author":"Skalhegg","year":"2005","journal-title":"Curr Drug Targets"},{"issue":"4","key":"10.1016\/j.mehy.2007.04.016_bib33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.mehy.2005.03.007","article-title":"Therapeutic and preventive interventions for postulated vasoactive neuropeptide autoimmune fatigue-related disorders","volume":"65","author":"Staines","year":"2005","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.mehy.2007.04.016_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mehy.2005.08.006","article-title":"Phosphodiesterase inhibitors may be indicated in the treatment of postulated vasoactive neuropeptide autoimmune fatigue-related disorders","volume":"66","author":"Staines","year":"2006","journal-title":"Med Hypotheses"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987707002964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987707002964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T08:29:17Z","timestamp":1683880157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987707002964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0306987707002964"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2007.04.016","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}